Literature DB >> 25789625

Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability.

Martin Heine1, Lizanne Eva van den Akker2, Olaf Verschuren1, Anne Visser-Meily1, Gert Kwakkel3.   

Abstract

BACKGROUND: Peak oxygen uptake (VO2peak) via cardiopulmonary exercise testing is considered the gold standard for testing aerobic capacity in healthy participants and people with various medical conditions. The reliability and responsiveness of cardiopulmonary exercise testing outcomes in persons with MS (PwMS) have not been extensively studied.
OBJECTIVE: (1) to investigate the reliability of cardiopulmonary exercise parameters in PwMS; (2) to determine the responsiveness, in terms of the smallest detectable change (SDC), for each parameter.
DESIGN: Two repeated measurements of cardiopulmonary exercise outcomes were obtained, with a median time interval of 16 days.
METHODS: Thirty-two PwMS suffering from subjective fatigue performed cardiopulmonary exercise tests on a cycle ergometer, to voluntary exhaustion. We calculated the reliability, in terms of the intra-class correlation coefficient (ICC [2,k]; absolute agreement), and the measurement error, in terms of standard error of measurement (SEM) and SDC at individual (SDCindividual) and group level (SDCgroup).
RESULTS: The ICC for VO2peak was 0.951, with an SEM of 0.131 L∙min(-1) and an SDCindividual of 0.364 L∙min(-1). When corrected for bodyweight, the ICC of VO2peak was 0.933, with an SEM of 1.7 mL∙kg(-1)∙min(-1) and in an SDCindividual of 4.6 mL∙kg(-1)∙min(-1). LIMITATIONS: Generalization of our study results is restricted to fatigued PwMS with a low to mild level of disability.
CONCLUSIONS: At individual level, cardiopulmonary exercise testing can be used reliably to assess physical fitness in terms of VO2peak, but less so to determine significant changes. At group level, VO2peak can be reliably used to determine physical fitness status and establish change over time.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25789625      PMCID: PMC4366200          DOI: 10.1371/journal.pone.0122260

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

1.  Validation of the portable VmaxST system for oxygen-uptake measurement.

Authors:  M-A Brehm; J Harlaar; H Groepenhof
Journal:  Gait Posture       Date:  2004-08       Impact factor: 2.840

Review 2.  The oxygen uptake efficiency slope: what do we know?

Authors:  Moniek Akkerman; Marco van Brussel; Erik Hulzebos; Luc Vanhees; Paul J M Helders; Tim Takken
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 Nov-Dec       Impact factor: 2.081

3.  Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.

Authors:  Martin Heine; Olaf Verschuren; Gert Kwakkel
Journal:  J Rehabil Med       Date:  2014-07       Impact factor: 2.912

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

6.  Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis.

Authors:  Karl-Heinz Schulz; Stefan M Gold; Jan Witte; Katharina Bartsch; Undine E Lang; Rainer Hellweg; Rüdiger Reer; Klaus-Michael Braumann; Christoph Heesen
Journal:  J Neurol Sci       Date:  2004-10-15       Impact factor: 3.181

Review 7.  General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.

Authors:  Ruth Ann Marrie; Heather Hanwell
Journal:  Continuum (Minneap Minn)       Date:  2013-08

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Assessing exercise limitation using cardiopulmonary exercise testing.

Authors:  Michael K Stickland; Scott J Butcher; Darcy D Marciniuk; Mohit Bhutani
Journal:  Pulm Med       Date:  2012-11-19

10.  The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.

Authors:  Heleen Beckerman; Lyan Jm Blikman; Martin Heine; Arjan Malekzadeh; Charlotte E Teunissen; Johannes Bj Bussmann; Gert Kwakkel; Jetty van Meeteren; Vincent de Groot
Journal:  Trials       Date:  2013-08-12       Impact factor: 2.279

View more
  3 in total

1.  An analysis of 2-day cardiopulmonary exercise testing to assess unexplained fatigue.

Authors:  Jacob B Lindheimer; Thomas Alexander; Wei Qian; Jacquelyn C Klein-Adams; Gudrun Lange; Benjamin H Natelson; Dane B Cook; Helene Z Hill; Michael J Falvo
Journal:  Physiol Rep       Date:  2020-09

Review 2.  The pathophysiology of motor fatigue and fatigability in multiple sclerosis.

Authors:  Robert Patejdl; Uwe K Zettl
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

3.  The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis.

Authors:  Heleen Beckerman; Martin Heine; Lizanne E van den Akker; Vincent de Groot
Journal:  NeuroRehabilitation       Date:  2019       Impact factor: 2.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.